Bloomberg News

Abbott’s $14.7 Billion Bond Set to Be Biggest in U.S. Since 2009

November 05, 2012

Abbott Laboratories (ABT:US) is planning to sell $14.7 billion of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.

Through its AbbVie Inc. pharmaceutical unit, Abbott may sell bonds in six parts ranging in size from $500 million to $4 billion, according to a person familiar with the transaction.

The offering is the largest dollar-denominated sale since February 2009, when Roche Holding AG issued $16 billion of debt, Bloomberg data show.

To contact the reporter on this story: Sarika Gangar at sgangar@bloomberg.net

To contact the editor responsible for this story: John Parry at jparry5@bloomberg.net


Video Game Avenger
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • ABT
    (Abbott Laboratories)
    • $44.25 USD
    • 0.09
    • 0.2%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus